跳至主要内容
临床试验/NCT01713933
NCT01713933已完成不适用

Evaluation of the Ulthera® System for Obtaining Lift and Tightening of the Brachia

Ulthera, Inc1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Ulthera, Inc
入组人数
37
试验地点
1
主要终点
Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity

研究概览

简要总结

This study is an evaluation of the Ulthera® System used to treat the upper arms for improvement of brachial ptosis. All enrolled subjects will receive one bilateral upper arm treatment. Follow-up visits will occur at 60, 90 and 180 days post-treatment.

详细描述

This is a prospective, non-randomized, clinical trial treating up to 35 subjects. Study photographs of the upper arms will be taken prior to treatment, immediately post-treatment, and at each follow-up visit. Brachial volume and dermal thickness measurements will be obtained.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Male or female, aged 19 - 55 years.
  • •Subject in good health.
  • •Subjects who desire lift and tightening of the brachia and improvement in skin laxity.
  • •Mild to moderate laxity of the upper arm.
  • •Mild to moderate subcutaneous fat of the upper arm.
  • •Mild crepiness of the skin of the upper arm.
  • •Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.
  • •Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

排除标准

  • •Presence of an active systemic or local skin disease that may affect wound healing.
  • •Severe solar elastosis.
  • •Excessive subcutaneous fat in the upper arm.
  • •Excessive skin laxity in the upper arm.
  • •Significant scarring in areas to be treated.
  • •Significant open wounds or lesions in the treatment areas.
  • •Severe or cystic acne in the treatment areas.

研究组 & 干预措施

Ultherapy™ treatment

Experimental

Each enrolled subject will receive a bilateral Ultherapy™ treatment of the upper arms

干预措施: Ulthera® System (Device)

结局指标

主要结局

Improvement in Obtaining Lift and Tightening of Brachial Skin Laxity

时间窗: Baseline to 90 days post-treatment

Improvement in overall lifting and tightening of brachial skin laxity as determined by masked, qualitative assessment of photographs at 90 days post-treatment compared to baseline.

次要结局

  • Overall Aesthetic Improvement(Baseline to180 days post-treatment)
  • Change in Dermal Thickness(Baseline to180 days post-treatment)
  • Patient Satisfaction(Baseline to 180 days post-treatment)
  • Quantitative Improvement in Skin Laxity(Baseline to 90 days post-treatment)
  • Change in Dermal Thickness(Baseline to 90 days post-treatment)
  • Overall Aesthetic Improvement(Baseline to 60 days post-treatment)
  • Overall Aesthetic Improvement(Baseline to 90 days post-treatment)
  • Patient Satisfaction(Baseline to 90 days post-treatment)

研究者

发起方
Ulthera, Inc
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验